Clinical Trials Information

Below you’ll find a list of both current and recently completed clinical trials

Inovio Pharmaceuticals

INO-3107 With Electroporation (EP) in Participants With HPV-6 Associated Recurrent Respiratory Papillomatosis (RRP)

United Kingdom: Airway Intervention Registry-Enrolling

NIH TRIAL: Adjuvant PRGN-2102 in Adults Patients with Recurrent Respiratory Papillomatosis-Enrolling

Mass General Trial Lenvatinib and Pembrolizumab Combination Therapy In HPV-associated Recurrent Respiratory Papilloma Patients With Laryngeal, Tracheal, and/or Pulmonary Involvement

CLINICAL TRIAL – NOT YET ENROLLING

Mass General Trial Pembrolizumab for HPV-associated Recurrent Respiratory Papilloma Patients With Laryngeal, Tracheal and/or Pulmonary Involvement

CLINICAL TRIAL – NO LONGER ENROLLING

NIH M7824 in People With Recurrent Respiratory Papillomatosis

COMPLETED CLINICAL TRIAL

NIDCD trial for aggressive RRP patients over 18 years old using anti-PD-L1 antibody therapy-Avelumab

COMPLETED CLINICAL TRIAL

Breaking News!!!

RRPF President, Kim McClellan to speak at the White House Rare Disease Forum

Tonight! February 28th @ 5:30PM EST